Latest updates on AML and what this means for you

This webinar will provide advice on the latest updates on AML and what this means for you.

8 February 2022

This webinar is aimed at patients and advocates to provide an overview of latest developments in the treatment of AML that were presented at The American Society of Haematology (ASH) Conference in Georgia, US, December 2021.

We will be joined by:

  • Dr Steven Knapper, Senior Lecturer and Honorary Consultant Haematologist at the University Hospital Wales

This webinar is being organised as a collaboration between the Acute Leukaemia Advocates Network and Leukaemia Care.

Webinar details

Date: Tuesday 8th February
Time: 3:30pm
Topic: Latest updates on AML and what this means for you
Host: Leukaemia Care

How do I join the webinar? 

The webinar is being hosted on Zoom and Facebook, meaning you can choose a platform to suit you. Zoom is the best place to ask questions, but if you join via Facebook we will try and get all the questions sent over to our panel; however, please expect a delay.

Information on how to join via Zoom or Facebook is below. 

Watch via Zoom

To join via Zoom, all you need to do is register your attendance before the webinar starts. You will then receive an email inviting you to join the webinar on the day.

Watch via Facebook

To join via Facebook, all you need is a Facebook account. Once logged in head to Leukaemia Care’s Facebook page at 3:30pm on 8th February and find the live video (it will be at the top of our feed).

Book your place via Zoom here.

Join on Facebook on the day here.

Please note, we will not be able to give individual medical advice. You will be directed to your own clinical team if we cannot answer your question in the webinar.

Due to the large amount of registrants, we cannot guarantee that everyone’s questions will be answered, but we will try and do our best in the time frame that we have.

If you have any issues registering via Zoom or issues on the day, please get in touch by emailing

Summary of JCVI advice on third vaccines and boosters for the clinical community

We have put together a summary of eligibility for the third vaccine and booster programmes and how patients should be communicated with below.

Read More